Why has Kim’s morning sickness cure caused such controversy?
Uh-oh, one of social media’s most avid users seems to have gotten herself into some trouble with a recent selfie.
Nope, it wasn’t that nude snap she shared with her 42 million followers yesterday. Instead, it was a photograph in which she discussed the product that has helped her battle her morning sickness that has landed her in hot water.
Kim, 34, is pregnant with her second child and has made no secret of her morning sickness issues both during this pregnancy and when she was pregnant with daughter North.
However, the Food and Drug Administration in the United States has sent the star a warning letter after it appeared that her post was promoting a morning sickness medication called Diclegis.
The FDA have called Kim’s post “false or misleading” and said it “fails to communicate any risk information associated with its use and it omits material facts.”
So does this mean Diclegis is potentially a harmful drug?
ET Online contacted the FDA for comment on the letter and were told the FDA “will not state our intentions regarding Duchesnay” the company which made the drug Kim was promoting.
They did also add:
“The Warning Letter is the company’s notification that we found what appears to be violations to the Federal Food Drug and Cosmetic Act.”
Which means that if they don’t address the issues the FDA have discovered they risk the drug being banned. They explained:
“Companies that do not correct citations in warning letters, or show that those citations are unfounded, risk enforcement action such as seizure.”
